Focus on internationalization at Investor Day

Around two dozen analysts and investors attended the CPH Group Investor Day at the Hotel Schweizerhof in Zurich on 16 September 2025. Alois Waldburg-Zeil, CEO of the CPH Group, provided an update on business development and placed the latest M&A activities in the context of the company’s overall strategy.

Following three acquisitions – Sorbchem India in India and SiliCycle in Canada from Zeochem, and LOG Pharma in Israel and Hungary from Perlen Packaging – over the past 18 months, the focus is now on integrating the acquired companies and leveraging the expected synergies. For example, SiliCycle ideally complements Zeochem’s existing business to expand the chromatography gel business, while LOG Pharma gives Perlen Packaging more direct access to the attractive Eastern European markets. ‘We want to exploit the full potential of the acquired companies, develop new markets and further expand the distribution network and thus our proximity to customers,’ said Waldburg-Zeil. The focus is on developing high-quality and innovative products in order to further strengthen the leading market positions in the respective market segments.

Further details can be found in the CPH Group presentation.